SOPHARMA AD (73/2019) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of December 6, 2019
Report no 73/2019
- 09.12.2019, 11:41
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
-
SOPHARMA AD (72/2019) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of December 5, 2019
Report no 72/2019- 06.12.2019, 13:59
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (71/2019) Sales revenues for November 2019
Report no 71/2019- 05.12.2019, 14:43
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (70/2019) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of December 4, 2019
Report no 70/2019- 05.12.2019, 13:47
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (67/2019) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of December 3, 2019.
Report no 67/2019- 04.12.2019, 12:02
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (66/2019) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of December 2, 2019
Report no 66/2019- 03.12.2019, 13:46
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (65/2019) Q3 2019 Consolidated Financial report of Sopharma Group.
Report no 65/2019- 29.11.2019, 14:52
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (64/2019) Sopharma AD is among the largest investors in Moldova
Report no 64/2019- 14.11.2019, 14:39
- Kategoria: Biznes i finanse
- Źródło: ESPI
